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Abstract: Radiofrequency plasma for biomedical applications generated in coaxial geometry 
at atmospheric pressure was investigated. The plasma was characterized by key parameters, 
including gas temperature and electron density. It was shown that OH rotational temperature 
is in agreement with the temperature estimated by Rayleigh and Raman scattering techniques. 
RF plasma was combined with an aerosol injection for better control of the treated skin 
temperature and topical drugs delivery.  
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1.Introduction   
The use of non-equilibrium discharges for wound 
healing or even its disinfection has been reported in 
recent literature as a promising technology [1,2]. The 
plasma techniques used in skin and wound healing used 
to be limited only to simple cutting and coagulation, but 
recently larger progress has been made in studies of 
healing chronical wounds like ulcers and plasma 
treatment of wounds for faster healing and/or reduction 
of bacteria [3]. However, the new research confirmed 
that the effectiveness of plasma treatment strongly 
correlates with the production rate of active species in 
the discharge. The main active species taking part in 
disinfection are O, O3, H2O2, OH, metastables, nitrogen 
oxides, and UV radiation [4]. Atmospheric pressure 
plasmas can strongly decrease the survival rates of a 
wide range of bacteria and even viruses, which suggests 
incorporating plasma as an agent in sterilization 
procedures [5]. 
Very new unexplored field of atmospheric plasma 
application is the transdermal and topical molecules 
delivery. Transdermal molecules delivery offers an 
attractive non-invasive alternative to the conventional 
delivery methods such as oral administration and 
injection. The main advantage of the delivery through 
the skin is the possibility of molecules to enter the 
circulation, avoiding the metabolic processing of the 
delivered molecules into the liver. However, the stratum 
corneum acts as a limiting barrier, therefore only small 
lipophilic molecules have the ability to penetrate the 
skin at therapeutic rates by passive diffusion. 
Conventional transdermal delivery systems such as 
transdermal patches, enable controlled transdermal 
molecules delivery, but are applicable only to small, 
potent and lipophilic solutes and the transport of 
molecules across the skin is slow with lag times to reach 
steady-state fluxes in hours. Therefore, to deliver larger 
molecules with therapeutic levels, many clinical and 
physical methods were developed. Many studies were 
focused on so-called active strategies as sonophoresis, 
iontophoresis and electroporation [6,7]. At the same 
time plasma present a direction and a bridge between 
physical and chemical methods, which has not been 
explored.  
In this work we aim at development and 
characterization of plasma source capable of direct drug 
delivery to skin with no physical damage of the skin due 
to very low heat flux. The plasma source is developed 
for a specific medical application case, namely the use 
of a plasma for topical molecule introduction into the 
skin and body. A critical case is that of chronic wounds 
like ulcers, which cannot be healed by conventional 
means or drugs are used in excessive quantities. 
2.Experimental set-up and methods 
Plasma device was engineered of two coaxial 
aligned metal electrodes separated by a gap. Powered 
inner electrode was made of stainless steel with inner 
and outer diameters of 10 mm and 12 mm, respectively. 
The grounded outer electrode was made of aluminum 
with 14 mm inner diameter. Schematic of the source and 
applied diagnostics is shown in Figure 1. Plasma source 
was powered with RF generator CESAR 136 (Advanced 
Energy Industries) operating at 13.56 MHz with L-type 
matching box. Discharge was sustained with feed gas 
Ar. Depending on the application gas flow was chosen 
to be 2 slm (standard liter per minute), 3, and 4 slm. In 
case of gas flow higher than 4 slm the discharge cannot 
be sustained in stable mode. Plasma was formed at the 
tip of the nozzle in an annular shape effluent in ambient 
air. 
 
 
Figure 1. Schematic of the RF plasma source and 
applied diagnostics. Laser scattering system and fast 
imaging camera are not shown on the figure. 
 
For the purpose of drug delivery the aerosol of water or 
ethanol with dissolved drug was applied through the 
center of the plasma source. Aerosol was generated by 
ultrasonic generator working at 80 kHz with typical 
droplet size of 10’s of m and solvent flow rate in the 
range of 0.1-10 ml/min, depending on application. 
Electric current and voltage of the discharge were 
measured with IV probe (Vigilant) and were recorded 
with oscilloscope (LeCroy Wavesurfer). Fast imaging 
with 5 ns resolution was performed with a use of 
Hamamatsu ICCD camera with bandpass filter centered 
at 750 nm. For the purpose of diagnostics, emission 
spectroscopy in UV/Visible range with resolution of 
0.05 nm was applied coupled with laser scattering at 532 
nm used for detection of Rayleigh and Raman signal of 
the heavy species in the discharge effluent.  
 
3. Results and discussion 
Electrical breakdown leading to ignition of RF 
plasma can be achieved by application of RF forward 
power above 100 W. At high power above 30 W the 
discharge starts in γ-mode, which manifests as highly 
localized discharge sustained by secondary emission of 
the electrons from hot spot localized on one of the 
electrodes. The γ-mode discharge can be transfer to 
uniform and diffuse -mode by decreasing the RF 
forward power below limit of 30 W. At this power the 
discharge transits to α-mode filling the whole area 
between the electrodes. According to measurements the 
plasma source stable operating range is from 10 W 
(minimum RF power to sustain plasma) to 30 W (γ-
mode transition). In the case of adding nitrogen/air to the 
gas flow, for emission spectroscopy purposes, α-mode 
was in the range of power from 13 W to 30 W. Length 
of the visible effluent is in the range of 2.5 - 5 mm 
corresponding to minimum and maximum power. It is 
interesting to note that increase of the gas flow rate from 
2 to 4 slm has very little impact on electrical 
characteristics of the plasma source. However, at flow 
rate above 4 slm the discharge sustaining in stable 
regime is not possible and plasma randomly completely 
extinguished. Considering linear V/I characteristic of 
the discharge with a positive slope of 94.7 V/A the 
plasma operates in glow–like mode sustained by Ohmic 
electrons heating  indicating that the main ionization 
processes are driven by fast electrons accelerated in 
oscillating RF field. Sustained RF glow discharge is 
characterized by constant V/I phase difference of about 
88° that implies on stability of α-mode and discharge 
capacitive character.  
Evolution of plasma constituents during a RF cycle 
was experimentally studied by use of fast imaging of the 
discharge emission presented on Figure 2.  
 
Figure 2. Time resolved imaging of the discharge  with 
5ns exposure time: left) The images of Ar I emission. 
Time of the records is indicated in the offsets; right) 3D 
map of intensity for a case of 55.4 ns time frame with 
indication of the sheath formed near powered electrode. 
Time resolved imaging indicates formation of the sheath 
and development of strong intensive emission near 
virtual cathode. Based on energy and 
recombination/ionization processes analysis it has been 
revealed that the presence of the sheath in RF plasma 
allows stabilizing the discharge and generating uniform 
α-mode plasma without filaments or transition to γ-
mode. It also play an important role in formation of low 
temperature afterglow. The temperature of the afterglow 
has been measured by 3 different methods based on 
emission spectroscopy, Rayleigh and Raman laser 
scattering.  
The Rayleigh radial resolved signal presented on 
Figure 3 has been averaged along of the laser beam in 
order to determine space averaged Tg which can be 
directly compared with emission spectroscopy 
measurements. Obtained results of Rayleigh scattering 
as a function of gas flow rate and forward RF power are 
presented on Figure 3. Obtained results indicate that Tg 
in plasma without aerosol is in the range of 300-350±15 
K, depending on applied flow and power. As presented 
on Figure 3, the RF power growth results in almost 
linear increase of gas temperature of the effluent. The 
maximum increase of 20 K was found for smallest flow 
rate of Ar gas due to less effective heat transfer at small 
flow. Radial averaged value of Tg measured by the 
Rayleigh scattering is in very good agreement with OES 
method based on OH(A-X) emission. 
 
Figure 3. Radial averaged temperature vs RF power. 
 
 Considering application of develop source for 
enhanced drug delivery additional set of tests has been 
performed to study two effect: 
(i) Effect of skin (or skin simulation material) 
in contact with effluent on gas phase 
temperature and thermal damage of skin 
(ii) Effect of aerosol injection on thermal 
impact of plasma on skin surface. 
Typical thermal pattern of plasma in contact with 
Biobrain® skin simulation material located at 2 mm 
distance from the nozzle is shown on figure 4. 
 
Figure 4. Thermal image of skin udner plasma exposure 
of 1 min at flow rate of 4 slm and RF power of 15 W with 
hot spot indication of 55.6 0C.  
Presence of surface/plasma interface drastically change 
gas flow dynamics and leads to higher temperature of 
the surface in regards to situation of effluent propagation 
in the ambient air. This effect is stronger at lower flow 
rates and higher RF power. At 2 slm gas flow it 
apparently can lead to surface damage due to high 
thermal flux to the surface. However, such a negative 
drawback of plasma treatment can be overcome by 
application of aerosol injection in the plasma effluent. 
To this end two types of solutions (without addition of a 
drug) where studied for aerosol generation: water and 
ethanol. It was found that flow of aerosol can be used to 
precisely control temperature of the substrate and insure 
safe operation of plasma source for a long treatment time 
of 5-10 minutes without any detectable thermal damage 
of Biobrain® skin simulation material.  
4.Conclusions 
The radio-frequency atmospheric pressure plasma 
source combined with aerosol injection was 
characterized by the meaning of electrical and plasma 
diagnostics. Plasma source was designed for topical skin 
drug delivery. It is revealed based on electrical 
characterization and RF imaging that the discharge is a 
capacitive coupled RF plasma operating in diffuse  
mode at RF power below 30 W. Phase resolved imaging 
shows that the bulk plasma between the electrodes is 
limited by the sheath regions of approximately 200 μm 
thickness located nearby the electrodes. One of the key 
parameters, gas temperature, is determined based on 
emission spectroscopy and validated by two other 
independent techniques based on laser scattering. 
Rayleigh scattering has shown uniform temperature 
distribution in the effluent and it is in a good agreement 
with OH rotational temperature determined by emission 
spectroscopy.  
It is found that presence of artificial skin material 
in direct contact with the effluent has a drastic impact on 
heat distribution in the afterglow. It can lead to heat 
damage of the substrate even when gas temperature in 
the effluent is below 500 C. It is shown that injection of 
an aerosol of water or ethanol in the effluent results in a 
drop of the substrate temperature below a critical point 
of substrate damage. The method can be used for precise 
control of the skin heating induced by the discharge in 
biomedical applications and also for transepidermal 
delivery of drugs enhanced by direct interaction of 
plasma activated media with skin surface.  
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